PTC Therapeutics Earnings Preview
PTC Therapeutics (NASDAQ:PTCT) is gearing up to announce its quarterly earnings on Thursday, 2025-08-07. Here's a quick overview of what investors should know before the release.
Analysts are estimating that PTC Therapeutics will report an earnings per share (EPS) of $-1.07.
The announcement from PTC Therapeutics is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
Historical Earnings Performance
Last quarter the company beat EPS by $10.74, which was followed by a 12.63% increase in the share price the next day.
Here's a look at PTC Therapeutics's past performance and the resulting price change:
| Quarter | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.70 | -0.65 | -1.44 | -1.05 |
| EPS Actual | 10.04 | -0.85 | -1.39 | -1.29 |
| Price Change % | 13.0% | 9.0% | 3.0% | -4.0% |
Stock Performance
Shares of PTC Therapeutics were trading at $51.11 as of August 05. Over the last 52-week period, shares are up 56.7%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
To track all earnings releases for PTC Therapeutics visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
